Cargando…

Anti-activated factor × response to enoxaparin in critically ill patients

Detalles Bibliográficos
Autores principales:	Einav, S, Dezigibker, I, Naamad, M, Hersch, M, Bitran, D, Shemesh, D, Zevin, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084325/ http://dx.doi.org/10.1186/cc7603

Ejemplares similares

Prokinetics effect on gastric emptying in critically ill ventilated patients measured by the C13 breath test with a novel device
por: Hersch, M, et al.
Publicado: (2007)

Use of anti-Xa factor titration as efficacy marker of enoxaparin in critically ill patients
por: Lage, S, et al.
Publicado: (2006)

Efficacy and safety of enoxaparin as deep vein thrombosis prophylaxis in critically ill patients
por: Al-Hubail, R, et al.
Publicado: (2012)

Intravenous paracetamol (Prodafalgan) causes hypotension in critically ill patients
por: Hersch, M, et al.
Publicado: (2004)

Leucocytosis in critically ill patients is not always a sign of infection!
por: Izbicki, G, et al.
Publicado: (2002)

Correlation of systemic protein S100β levels with postoperative indicators of neurological damage in supratentorial meningioma surgery
por: Einav, S, et al.
Publicado: (2006)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Effective dosage of enoxaparin for intensive care patients
por: Robinson, S, et al.
Publicado: (2013)

Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006)

Brachial cuff measurements for fluid responsiveness prediction in the critically ill
por: Lakhal, K, et al.
Publicado: (2011)

Preliminary report of an enoxaparin dose protocol based on anti-Xa activity in continuous renal replacement therapy
por: Costa, JLF, et al.
Publicado: (2007)

Risk factors for death in chronic critical illness
por: Lokhandwala, S, et al.
Publicado: (2015)

Persistent hypoproteinemia is an independent risk factor for critical illness polyneuromyopathy
por: Kritikos, K, et al.
Publicado: (2006)

Acute exercise response in the critically ill
por: Collings, N, et al.
Publicado: (2013)

Predicting response to recombinant activated factor VIIa administration in the critically ill
por: Pugh, R, et al.
Publicado: (2008)

Effect of critical illness on the pharmacokinetics and dose-response relationship of midazolam
por: Ovakim, D, et al.
Publicado: (2012)

The Critically Ill Adults scale
por: Schoonderbeek, J, et al.
Publicado: (2005)

Gram-negative bacteremia is an independent predisposing factor for critical illness polyneuromyopathy
por: Kritikos, K, et al.
Publicado: (2007)

Predicting a low response to ACTH in the critically ill
por: de Jong, M, et al.
Publicado: (2006)

Alterations in adipose tissue during critical illness: an adaptive and protective response?
por: Langouche, L, et al.
Publicado: (2010)

The reliability of electrocardiogram interpretation in critically ill patients
por: Lim, W, et al.
Publicado: (2005)

Renal replacement in critically ill patients: the age factor
por: Occhigrossi, F, et al.
Publicado: (2004)

Efficacy and utility of preemptive anti-Gr(+) coverage in selected critically ill patients
por: Todorova, VT, et al.
Publicado: (2013)

Risk factors for unplanned extubations in critically ill patients, using PRISMA analysis
por: Herold, I, et al.
Publicado: (2006)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

The risk factors for intra-abdominal hypertension in a mixed population of critically ill patients
por: Chiumello, D, et al.
Publicado: (2004)

Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
por: Zufferey, Paul Jacques, et al.
Publicado: (2021)

Investigation into the effects of commencing haemodialysis in the critically ill
por: Docking, R, et al.
Publicado: (2012)

Coagulation disorders and the role of tissue factor and tissue factor pathway inhibitor in critically ill patients
por: Frantzeskaki, F, et al.
Publicado: (2015)

Risk factors for bronchial acquisition of resistant Gram-negative bacteria in critically ill patients and outcome
por: Papakonstantinou, I, et al.
Publicado: (2012)

Risk factors for unplanned extubation in critically ill patients
por: De Groot, RI, et al.
Publicado: (2009)

Arrhythmia incidence and risk factors in critically ill patients
por: Tasdemir, G, et al.
Publicado: (2015)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Modifiable risk factors for delirium in critically ill trauma patients: a multicenter prospective study
por: Duceppe, MA, et al.
Publicado: (2015)

Critically ill patients with cancer and sepsis: clinical course and prognostic factors
por: Rabello, LSCF, et al.
Publicado: (2011)

Seropositivity incidence of anti-Toxoplasma gondii antibodies in critically ill intensive care unit patients
por: Can, ÖS, et al.
Publicado: (2007)

Fibroblast growth factor 21 response to critical illness: effect of blood glucose control and relation with mitochondrial dysfunction, the integrated stress response and survival
por: Thiessen, S, et al.
Publicado: (2015)

Increased glomerular filtration in the critically ill patient receiving anti-infective treatment
por: Claus, B, et al.
Publicado: (2010)

Outcome and prognostic factors in critically ill immunocompromised patients admitted to the ICU
por: Schellongowski, P, et al.
Publicado: (2004)

Selenium and its substitution in critically ill patients
por: Kazda, A, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_tui8rbhn0kc85phh7ch0227ibk